Gilead Sciences Inc

Common Name
Gilead Sciences
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
17,600
Ticker
GILD
Exchange
NASDAQ/NGS
Description
Gilead Sciences Inc. is a biopharmaceutical company that focuses on researching, developing, and commercializing innovative medicines in areas of unmet medical need. It is globally recognized for its ...

Gilead Sciences's Climate Target Data Preview

As of 2024, Gilead Sciences has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Gilead Sciences ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a, b
2030
Absolute-based Target
Scope 3 - Purchased Goods and Services (Cat. 1), Scope 3 - Capital Goods (Cat. 2), Scope 3 - Fuel- and Energy-Related Services (Cat. 3), Scope 3 - Upstream Transportation and Distribution (Cat. 4), Scope 3 - Downstream Transportation and Distribution (Cat. 9), Scope 3 - Waste Generated in Operations (Cat. 5), Scope 3 - Business Travel (Cat. 6), Scope 3 - Employee Commuting (Cat. 7), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Investments (Cat. 15)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy restricted. Please purchase to unlock this data.
a, b
2030
Download Data

Verified Sources Behind Gilead Sciences’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gilead Sciences’s data sources below and access millions more through our Disclosure Search.

a. Gilead Sciences's Impact Report 2024
a. Gilead Sciences's Impact Report 2024
b. Gilead Sciences's ESG Data Spreadsheet 2024
b. Gilead Sciences's ESG Data Spreadsheet 2024

Insights into Gilead Sciences's Greenhouse Gas Emissions Pathways

As of 2024, Gilead Sciences has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint. a b

Does Gilead Sciences have a target to reduce the emissions from its operations?

As of 2024, Gilead Sciences has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a b

Gilead Sciences's most ambitious operational target is to reduce these emissions by 46% by 2030, compared to a baseline of 87,551 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019. a b

As of 2024, Gilead Sciences is lagging behind on its operational emissions reduction target, having achieved 41.11% of the planned reduction. a b

Gilead Sciences's Operational (Scope 1+2) Emissions Pathway

201920242030025 k50 k75 k100 kBaselineCurrent (-19%)Target 2030 (-46%)

Does Gilead Sciences have a target to reduce the emissions from its value chain?

As of 2024, Gilead Sciences has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a b

Gilead Sciences's most ambitious value chain target is to reduce these emissions by 15% by 2030, compared to a baseline of 972,587 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019. a b

Instead of reducing value chain emissions, Gilead Sciences has increased them, with 2024 levels exceeding those of the 2019 baseline, placing the company well behind its reduction target. a b

Gilead Sciences's Value Chain (Scope 3) Emissions Pathway

2019202420300250 k500 k750 k1 MCurrent (+3%)Target 2030 (-15%)
Want Full Access to Gilead Sciences's Climate Targets Dataset?
Sign Up